Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase NA 8Phase 1 8Phase 3 5Phase 1/2 5Phase EARLY_PHASE1 4

Status

Active not recruiting 2Withdrawn 1Recruiting 1Completed 1

Sponsor Class

NIH 3NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Sarcoma 4Genitourinary 3Gynecologic 2CNS 2Thoracic 1Other hematologic neoplasm 1NET 1Lymphoid 1Endocrine 1

Conditions

Pancreatic Intraductal Neoplasms 1Non functioning pancreatic endocrine tumor 1Neuroendocrine Tumors 1Colorectal Neoplasms 1Barrett Esophagus 1Anus Neoplasms 1Anal Canal Carcinoma 1Adenoma, Islet Cell 1

Interventions

Fluorouracil 308Oxaliplatin 259Leucovorin 233Capecitabine 198Irinotecan 145Gemcitabine 127Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 63Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 41S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36Surgical Procedures, Operative 27130-nm albumin-bound paclitaxel 27regorafenib 25lenvatinib 24XELOX 24Panitumumab 24Radiation 23Nivolumab 22trifluridine tipiracil drug combination 21atezolizumab 21Carboplatin 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × X-Rays × Gastrointestinal × Clear all
NCT05863195 2026-05-15

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Eastern Cooperative Oncology Group

Phase 3 Recruiting
408 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03233711 2026-05-13

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
344 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT03375320 2026-05-01

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

National Cancer Institute (NCI)

Phase 3 Active not recruiting
298 enrolled 14 charts 1 FDA
EndocrineGastrointestinalNET

Non functioning pancreatic endocrine tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT01013649 2026-02-23

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

National Cancer Institute (NCI)

Phase 3 Completed
546 enrolled 29 charts
Gastrointestinal

Pancreatic Intraductal Neoplasms

NCT01209013 2012-05-08

Oedisse

Pinnacle Biologics Inc.

Phase 3 Withdrawn
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡